NCT07788365 clinical trial report covering TARLATAMAB-DLLE, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600131038 clinical trial report covering Cadonilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600130991 clinical trial report covering Irinotecan Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white spac

NCT07789574 clinical trial report covering Asciminib Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07789444 clinical trial report covering Sacituzumab tirumotecan, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07788950 clinical trial report covering BL-M08D1, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07790913 clinical trial report covering Phentermine Hydrochloride/Topiramate, Phase 2, endpoints, sponsor, geography, readout timing and development whi

NCT07789522 clinical trial report covering Elranatamab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07791043 clinical trial report covering Efimosfermin alfa, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600131102 clinical trial report covering Adebrelimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07789873 clinical trial report covering MRZ-99030, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07791654 clinical trial report covering MWN-109, Phase 2, endpoints, sponsor, geography, readout timing and development white space.